Teekay director sells 11,585 shares after exercise

A Teekay director exercised stock options and sold the resulting 11,585 common shares on September 10, 2026, while retaining 10,000 options.

Rhea-AI Filing Summary

TEEKAY CORP LTD (TK) director Heidi Simon Locke exercised stock options and sold the resulting shares. On September 10, 2026, she exercised options to acquire 11,585 shares of common stock at an exercise price of $5.81 per share, then sold 11,585 shares of common stock in an open-market or private transaction at a weighted average price of $14.0802 per share, executed in multiple trades between $14.080 and $14.085. Following the option exercise, she continued to hold 10,000 stock options directly. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Exercise and Sale: 11,585 shares ($96K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Locke Simon Heidi

Role Director

Sold 11,585 shs ($163K)

Approx. gross sale proceeds $163K

Approx. exercise cost $67K

Approx. pre-tax spread $96K

Type	Security	Shares	Price	Value
Exercise	Stock Option ("Right to Buy")	11,585	$5.81	$67K
Exercise	Common Stock	11,585	$5.81	$67K
Sale	Common Stock F1	11,585	$14.0802	$163K

Holdings After Transaction: Stock Option ("Right to Buy") — 10,000 contracts (Direct); Common Stock — 46,000.5095 shares (Direct)

Footnotes (1)

1. F1. The transaction was executed in multiple trades at prices ranging from $14.080 to $14.085. The price reported above reflects the weighted average sale price.

Key Figures

Shares acquired via option exercise: 11,585 shares Option exercise price: $5.81 per share Shares sold: 11,585 shares +3 more

6 metrics

Shares acquired via option exercise 11,585 shares Stock options for Teekay common stock exercised on September 10, 2026

Option exercise price $5.81 per share Exercise price for 11,585 stock options into Teekay common stock

Shares sold 11,585 shares Teekay common stock sold on September 10, 2026 after option exercise

Weighted average sale price $14.0802 per share Sale of 11,585 shares in multiple trades between $14.080 and $14.085

Remaining stock options held 10,000 options Stock options to purchase Teekay common stock held directly after the exercise

Option expiration date June 7, 2033 Expiration date for the stock options with a $5.81 exercise price

Key Terms

weighted average sale price

1 terms

weighted average sale price financial

"The transaction was executed in multiple trades at prices ranging from $14.080 to $14.085. The price reported above reflects the weighted average sale price."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Teekay (TK) director report in this Form 4?

The director reported exercising stock options for 11,585 shares of Teekay common stock at $5.81 per share and selling 11,585 shares at a weighted average of $14.0802 per share on September 10, 2026, while retaining 10,000 stock options.

How many Teekay (TK) shares did the director sell and at what price?

The director sold 11,585 shares of Teekay common stock at a weighted average price of $14.0802 per share. The sale was executed in multiple trades with prices ranging from $14.080 to $14.085 on September 10, 2026.

What was the option exercise price reported by the Teekay (TK) director?

The director exercised stock options to acquire 11,585 shares of Teekay common stock at an exercise price of $5.81 per share on September 10, 2026. These options are reported as originally exercisable from June 7, 2023, and expiring June 7, 2033.

How many Teekay (TK) stock options does the director hold after these transactions?

After the reported option exercise, the director holds 10,000 stock options directly. These remaining options relate to Teekay common stock and have an exercise price of $5.81 per share, with an expiration date of June 7, 2033.

Were the Teekay (TK) director’s transactions under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with these transactions. The option exercise and share sale on September 10, 2026, are not stated to be made under a pre-arranged trading plan.

What is the expiration date of the Teekay (TK) options involved in this Form 4?

The stock options exercised by the director, and the remaining 10,000 options, carry an expiration date of June 7, 2033. They are reported as stock options to purchase Teekay common stock at an exercise price of $5.81 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 03:20 PM Accepted by SEC EDGAR 09/11/2026 - 03:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Locke Simon Heidi

(Last) (First) (Middle)

C/O TEEKAY

2ND FL, SWAN BUILDING, 26 VICTORIA ST

(Street)

HAMILTON HM 12

(City) (State) (Zip)

BERMUDA

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEEKAY CORP LTD [ TK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		M		11,585	A	$5.81	57,585.5095	D
Common Stock	09/10/2026		S		11,585	D	$14.0802(1)	46,000.5095	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option ("Right to Buy")	$5.81	09/10/2026		M			11,585	06/07/2023	06/07/2033	Common Stock	11,585	$5.81	10,000	D

Explanation of Responses:

1. The transaction was executed in multiple trades at prices ranging from $14.080 to $14.085. The price reported above reflects the weighted average sale price.

Remarks:

	/s/ Heidi Locke Simon	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)